Physician profile
John M Sullivan
NPI 1336132117
$2,224.38
in general payments reported to CMS, 2019-2025
30 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $264 · 2021: $145 · 2022: $137 · 2023: $776 · 2024: $547 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,524.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $889.96 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Merck Sharp & Dohme LLC | $209.68 | 2021-2025 | Verquvo, Gardasil 9, Capvaxive |
| Endo Pharmaceuticals INC. | $159.83 | 2020 | |
| Novo Nordisk INC | $130.49 | 2021-2025 | Ozempic, Rybelsus |
| Acell, INC. | $120.18 | 2019 | |
| Boston Scientific Corporation | $115.93 | 2020-2023 | Watchman Access System, Resolution 360 Clip |
| Medtronic, INC. | $81.25 | 2022-2023 | Cobalt Dr Mri Surescan |
| Lilly USA, LLC | $68.05 | 2020-2023 | Jardiance, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.51 | 2019-2024 | Jardiance |
| Amgen INC. | $32.28 | 2024 | Evenity |
| Astrazeneca Pharmaceuticals LP | $30.23 | 2021-2024 | Farxiga |
| Inspire Medical Systems, INC. | $28.83 | 2023 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $28.45 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.24 | 2022 | |
| Pfizer INC. | $24.94 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.43 | 2020-2021 | |
| Tela Bio, INC. | $20.18 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Philips North America LLC | $19.45 | 2020 | |
| Viatris Specialty LLC | $19.26 | 2025 | Yupelri |
| Ge Healthcare | $17.29 | 2019 | |
| Axsome Therapeutics, INC. | $17.08 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $16.74 | 2021 | |
| Arbor Pharmaceuticals, INC. | $16.49 | 2021 | |
| Smith+Nephew, INC. | $15.79 | 2023 | Pico |
| Organogenesis INC. | $15.41 | 2020 | |
| Paratek Pharmaceuticals, INC. | $14.43 | 2025 | Nuzyra |
| Scpharmaceuticals INC. | $14.15 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.28 | 2024 | Lifevest |
| Glaxosmithkline, LLC. | $11.57 | 2021 | |
| Janssen Pharmaceuticals, INC | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.